These benefits, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the principle of targeting ACKR3 as a singular method to modulate the opioid process, which could open up new therapeutic avenues for opioid-related disorders. Continual pain is complicated, and https://ambrosef172umc7.activablog.com/profile